Analysts and estimates

The following financial analysts monitor the market environment and the performance of Aurubis AG and make investment recommendations in accordance with their analyses and reports on Aurubis shares. The following list is not necessarily exhaustive.

Buy (overweight/outperform/add): The price of the analyzed share is expected to rise over the next 12 months.

Hold (equal-weight/neutral): The price of the analyzed share is expected to remain mostly flat over the next 12 months.

Sell (underweight/underperform/reduce): The price of the analyzed share is expected to fall over the next 12 months.

Company	Analyst	Recommendation	Target price in €
Baader Bank	Christian Obst	Buy	110
Bank of America	Jason Fairclough	Sell	67
Deutsche Bank	Bastian Synagowitz	Hold	100
DZ Bank AG	Dirk Schlamp	Buy	105
Exane BNP Paribas	Jatinder Goel	Hold	94,50
Kepler Cheuvreux	Rochus Brauneiser	Sell	70
LBBW	Jens Münstermann	Hold	95
M.M. Warburg	Stefan Augustin	Buy	110
Morgan Stanley	Ioannis Masvoulas	Hold	91
Metzler	David Varga	Buy	139
Oddo BHF	Maxime Kogge	Buy	136

Data as of May 9, 2023

Legal disclaimer

Note: The analyst estimates presented are not based on research conducted by Aurubis AG, but on the assessments, reports, recommendations, and analyses of the listed equity research analysts. The presentation of this information as a service for our shareholders does not mean that Aurubis AG adopts, supports, or confirms the analysts' recommendations. None of the data and information provided on this website constitutes an offer to buy, sell, or otherwise trade in securities. In particular, the information does not contain any recommendation for an investment strategy. Aurubis AG accepts no liability whatsoever for the selection, completeness, or correctness of the analysts' assessments presented here. Aurubis AG accepts no liability for damages incurred by third parties as a result of information on this website.